Polianta LTD United Therapeutics Corp Transaction History

Polianta LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$174.81 - $241.14 $874,050 - $1.21 Million	-5,000 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$166.16 - $213.96 $830,800 - $1.07 Million	5,000 New	5,000 $897,000
Q4 2021 Jan 18, 2022	SELL	$184.32 - $216.08 $1.16 Million - $1.36 Million	-6,300 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$179.86 - $214.88 $1.13 Million - $1.35 Million	6,300 New	6,300 $1.16 Million
Q1 2021 Apr 14, 2021	SELL	$153.94 - $174.85 $1.37 Million - $1.56 Million	-8,900 Closed	0 $0
Q4 2020 Jan 13, 2021	SELL	$101.87 - $151.79 $183,366 - $273,222	-1,800 Reduced 16.82%	8,900 $1.35 Million
Q3 2020 Oct 07, 2020	BUY	$99.9 - $121.13 $1.07 Million - $1.3 Million	10,700 New	10,700 $1.08 Million

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.